Market Reactions and Regulatory Concerns

This chapter explores the tumultuous reactions following a major deal in the pharmaceutical sector, particularly the decline in vaccine stocks after a new FDA appointment. It also examines the anticipated earnings and market implications for companies like Wynn, Rivian, and Lucid Motors amidst ongoing economic uncertainties and trade tensions.